Medicare Enrolled
Dr. Eric Batts, M.D.
Hematology & Oncology · Holland, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Batts from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Batts?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Batts
Dr. Eric Batts is a hematology & oncology specialist in Holland, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Batts performed 43,313 Medicare services across 2,347 unique beneficiaries.
Between the years covered by Open Payments, Dr. Batts received a total of $9,114 from 65 pharmaceutical and/or device companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Batts is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in MI
$9,114 industry payments
Medicare Practice Summary
Medicare Utilization ↗43,313
Medicare services
Top 13% in MI for hematology & oncology
2,347
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,280 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
26,250 | $1 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,950 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,040 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,427 | $8 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,345 | $8 | $26 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,210 | $1 | $31 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,057 | $10 | $35 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
523 | $11 | $34 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
502 | $89 | $189 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
391 | $93 | $292 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
291 | $7 | $25 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 279 | $133 | $354 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
193 | $9 | $32 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
182 | $72 | $70 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
167 | $56 | $133 |
| PSA test (prostate cancer screening) | 166 | $18 | $63 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
154 | $20 | $47 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
132 | $6 | $20 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
130 | $45 | $151 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
127 | $127 | $264 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
124 | $17 | $43 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
121 | $7 | $23 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
109 | $13 | $46 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
102 | $9 | $26 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
94 | $1 | $2 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
93 | $2 | $4 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
88 | $16 | $57 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
88 | $20 | $66 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
85 | $47 | $142 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
78 | $10 | $38 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
62 | $11 | $37 |
| Iron level test | 59 | $6 | $22 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
59 | $14 | $41 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
56 | $21 | $72 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
55 | $24 | $84 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
43 | $4 | $15 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
41 | $92 | $180 |
| Hepatitis B surface antigen test A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body. |
33 | $10 | $26 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
32 | $19 | $65 |
| Hepatitis B surface antibody test A blood test that measures the level of antibodies against the hepatitis B surface antigen. This test is used to check for immunity to hepatitis B or to verify the effectiveness of the hepatitis B vaccine. |
32 | $10 | $27 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
31 | $4 | $11 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
30 | $5 | $14 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
28 | $25 | $88 |
| Hepatitis B core antibody test A blood test that measures the level of antibodies to the hepatitis B core antigen. This test helps determine if a person has been infected with the hepatitis B virus. |
28 | $12 | $30 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
26 | $13 | $44 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
25 | $5 | $16 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
25 | $4 | $13 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
25 | $25 | $83 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
23 | $9 | $31 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
21 | $15 | $51 |
| New patient office visit, complex (60-74 min) | 21 | $161 | $324 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
16 | $15 | $55 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
15 | $8 | $29 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $100 | $222 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $134 | $304 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
62.7% high complexity
21.8% medium
15.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,114
Total received (2018-2024)
Avg $1,302/year across 7 years
Top 19% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
332
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,064 (88.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$997 (10.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$52 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,035
2023
$2,296
2022
$1,268
2021
$36
2020
$21
2019
$1,550
2018
$1,907
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$285
Novartis Pharmaceuticals Corporation
$186
PFIZER INC.
$172
Eisai Inc.
$170
Takeda Pharmaceuticals U.S.A., Inc.
$98
ABBVIE INC.
$98
Janssen Biotech, Inc.
$91
Merck Sharp & Dohme LLC
$86
BeiGene USA, Inc.
$79
Genentech USA, Inc.
$77
ARRAY BIOPHARMA INC
$65
GlaxoSmithKline, LLC.
$56
Incyte Corporation
$56
PUMA BIOTECHNOLOGY, INC.
$53
E.R. Squibb & Sons, L.L.C.
$51
Astellas Pharma US Inc
$45
SpringWorks Therapeutics, Inc.
$34
SUN PHARMACEUTICAL INDUSTRIES INC.
$30
Bayer Healthcare Pharmaceuticals Inc.
$29
Regeneron Healthcare Solutions, Inc.
$27
Daiichi Sankyo Inc.
$25
ADC Therapeutics America, Inc.
$25
SERVIER PHARMACEUTICALS LLC
$25
Stemline Therapeutics Inc.
$24
SOBI, INC
$23
Kyowa Kirin, Inc.
$20
PharmaEssentia USA Corporation
$19
Lilly USA, LLC
$19
EMD Serono, Inc.
$18
Gilead Sciences, Inc.
$18
Sumitomo Pharma America, Inc.
$17
Mirati Therapeutics, Inc.
$16
Top 3 companies account for 31.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca AB
$1,467
Daiichi Sankyo Inc.
$1,129
AstraZeneca Pharmaceuticals LP
$631
Novartis Pharmaceuticals Corporation
$437
Genentech USA, Inc.
$396
PFIZER INC.
$341
Gilead Sciences, Inc.
$326
Takeda Pharmaceuticals U.S.A., Inc.
$320
Merck Sharp & Dohme LLC
$311
Eisai Inc.
$273
Astellas Pharma US Inc
$229
Janssen Biotech, Inc.
$224
Celgene Corporation
$147
Incyte Corporation
$144
Pharmacyclics LLC, An AbbVie Company
$143
Exelixis Inc.
$139
ABBVIE INC.
$120
Lilly USA, LLC
$119
Amgen Inc.
$117
Foundation Medicine, Inc.
$112
GlaxoSmithKline, LLC.
$109
BeiGene USA, Inc.
$98
AstraZeneca UK Limited
$95
ARRAY BIOPHARMA INC
$90
Pharmacyclics LLC, an AbbVie Company
$87
EMD Serono, Inc.
$83
E.R. Squibb & Sons, L.L.C.
$83
Seagen Inc.
$75
TerSera Therapeutics LLC
$73
GENZYME CORPORATION
$72
Mirati Therapeutics, Inc.
$69
Ipsen Biopharmaceuticals, Inc
$66
Kyowa Kirin, Inc.
$57
Karyopharm Therapeutics Inc.
$57
PUMA BIOTECHNOLOGY, INC.
$53
Progenics Pharmaceuticals, Inc.
$51
Bayer Healthcare Pharmaceuticals Inc.
$49
Jazz Pharmaceuticals Inc.
$45
Stemline Therapeutics Inc.
$43
SERVIER PHARMACEUTICALS LLC
$41
Rigel Pharmaceuticals, Inc.
$40
Sumitomo Pharma America, Inc.
$39
AbbVie Inc.
$37
SpringWorks Therapeutics, Inc.
$34
Merck Sharp & Dohme Corporation
$33
SUN PHARMACEUTICAL INDUSTRIES INC.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Regeneron Healthcare Solutions, Inc.
$27
ADC Therapeutics America, Inc.
$25
Myovant Sciences Inc.
$24
JAZZ PHARMACEUTICALS INC.
$24
Bayer HealthCare Pharmaceuticals Inc.
$23
SOBI, INC
$23
Taiho Oncology, Inc.
$22
TAIHO ONCOLOGY, INC.
$21
Octapharma USA, Inc.
$20
PharmaEssentia USA Corporation
$19
Acrotech Biopharma LLC
$19
Deciphera Pharmaceuticals Inc.
$17
EISAI INC.
$16
AbbVie, Inc.
$16
Array BioPharma Inc.
$15
Shire North American Group Inc
$14
Puma Biotechnology, Inc.
$14
CTI BioPharma Corp.
$14
Top 3 companies account for 35.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · Alecensa · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Cresemba · DARZALEX · DOPTELET · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · EXKIVITY · Enhertu · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · Neulasta · OCTAGAM · OGSIVEO · OJJAARA · ONGLYZA · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYLARIFY · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · Rozlytrek · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · Stivarga · TAGRISSO · TASIGNA · TECVAYLI · TEPMETKO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · Truqap · VENCLEXTA · VERZENIO · Vanflyta · Venclexta · Vitrakvi · Vonjo · XALKORI · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · ZEPZELCA · Zoladex · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
8
Per 100K population
2.7
County median income
$87,144
Nearest hospital
HOLLAND COMMUNITY HOSPITAL
6.9 mi
6.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Batts is a mixed practice specialist, with above-average Medicare volume (top 13% in MI), with low-engagement industry engagement in the top 19% of MI peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Batts experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Batts performed 26,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Batts receive payments from pharmaceutical companies?
Yes. Dr. Batts received a total of $9,114 from 65 companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Batts's costs compare to other hematology & oncology specialists in Holland?
Dr. Batts's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Batts) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Holland
Browse hematology & oncology specialists in Holland ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca AB Payments to Doctors
See all physicians who received payments from AstraZeneca AB.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology